AAV hybrid serotypes: improved vectors for gene delivery.
In recent years, significant efforts have been made on studying and engineering adeno-associated virus (AAV) capsid, in order to increase efficiency in targeting specific cell types that are non-permissive to wild type (wt) viruses and to improve efficacy in infecting only the cell type of interest. With our previous knowledge of the viral properties of the naturally occurring serotypes and the elucidation of their capsid structures, we can now generate capsid mutants, or hybrid serotypes, by various methods and strategies. In this review, we summarize the studies performed on AAV retargeting, and categorize the available hybrid serotypes to date, based on the type of modification: 1) transcapsidation, 2) adsorption of bi-specific antibody to capsid surface, 3) mosaic capsid, and 4) chimeric capsid. Not only these hybrid serotypes could achieve high efficiency of gene delivery to a specific targeted cell type, which can be better-tailored for a particular clinical application, but also serve as a tool for studying AAV biology such as receptor binding, trafficking and genome delivery into the nucleus.
Department of Pharmacology, University of North Carolina at Chapel Hill, NC 27599, USA.
Vivian W
VW
Choi
Douglas M
DM
McCarty
R Jude
RJ
Samulski
D000818:Animals; D036022:Capsid Proteins / Q000235:genetics; D000229:Dependovirus / Q000145:classification / Q000235:genetics* / Q000648:ultrastructure; D018014:Gene Transfer Techniques; D015316:Genetic Therapy / Q000379:methods*; D005822:Genetic Vectors; D006801:Humans; D011995:Recombination, Genetic; D012703:Serotyping
D036022:Capsid Proteins